Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
Perspective
Prescription Drug Affordability Boards Reshape Reimbursement While Leaving Core Problems Unresolved
Featured Experts: William Padula
In The News View All
Wall Street Journal
Wall Street Journal cites Schaeffer research on the rise in postpartum GLP-1 prescriptions
Featured Experts: Sih-Ting Cai
Politico
Joyce interviewed about California’s effort to sell cheaper, state-branded generic drugs
Featured Experts: Geoffrey Joyce
Medscape
Peters discusses how she addresses insurance denials for GLP-1s
Featured Experts: Anne Peters
Healthcare Brew
Padula discusses the economics and patient care risks of cancer drug shortages
Featured Experts: William Padula
CalMatters
Ward discusses tension between GLP-1 long-term savings and near-term insurer costs
Featured Experts: Alison Sexton Ward
Featured Perspective
A Missed Chance to Make America Healthier and Richer
Medicare should revisit its decision not to broadly cover anti-obesity medications, considering the enormous value expanded access would generate for society.
Experts: Alison Sexton Ward, Dana Goldman
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
